Reuters |
Amicus expects delay in filing for marketing rights for lead drug
Yahoo News Amicus had expected to submit a marketing application for the drug, migalastat, by the end of the year, hoping to be the first to give the U.S. market an oral treatment for patients with a form of Fabry disease. Fabry disease is an inherited disorder ... Amicus says likely to delay marketing application for lead drug |
October 02, 2015 at 12:06PM | marketing - Google News
Amicus expects delay in filing for marketing rights for lead drug - Yahoo News
marketing - Google News
Nenhum comentário:
Postar um comentário